Cedar Clinical Research

Mental healthcare company Numinus Wellness (OTCQX: NUMIF) announced its contract research organization Cedar Clinical Research (CCR) is a top research site for MindMed's (NASDAQ: MNMD) Phase 2b study on proprietary LSD compound MM-120 (lysergide D-tartrate) for General Anxiety Disorder (GAD.)...

Psychedelics mental healthcare company Numinus Wellness Inc. (OTCQX: NUMIF) announced its financial results for the three and six months ended Feb. 28, 2023. Q2 numbers show: Total cash of $14.7 (CA$19.7) million as of Feb. 28, 2023. Revenue of $4.03 million, a 581.1% year-over-year growth yet...

Novamind became the latest psychedelics company to go public through a reverse take-over with Hinterland Metals Inc. The company debuted in the Canadian Securities Exchange on Tuesday under the symbol "NM." In late November, Novamind closed a private placement for CA$10 million ($7.8...